In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

Scientists discovered that a blood molecule called CtBP2 may play a major role in how we age. It helps regulate metabolism ...

The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...

Could slightly elevated blood sugar levels lead to serious health problems in the future? A single patient's question sparked ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

The clinical hold follows Intellia's disclosure that it paused dosing in two Phase III trials after a patient experienced a serious adverse event.

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular ...

Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...